JP4703186B2 - 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法 - Google Patents

封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法 Download PDF

Info

Publication number
JP4703186B2
JP4703186B2 JP2004526684A JP2004526684A JP4703186B2 JP 4703186 B2 JP4703186 B2 JP 4703186B2 JP 2004526684 A JP2004526684 A JP 2004526684A JP 2004526684 A JP2004526684 A JP 2004526684A JP 4703186 B2 JP4703186 B2 JP 4703186B2
Authority
JP
Japan
Prior art keywords
csf
inclusion bodies
concentration
protein
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004526684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502708A (ja
Inventor
メナート，ビクトル
ガベルチポレカル，ブラドカ
イエブセバル，シモナ
Original Assignee
レツク・フアーマシユーテイカルズ・デー・デー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by レツク・フアーマシユーテイカルズ・デー・デー filed Critical レツク・フアーマシユーテイカルズ・デー・デー
Publication of JP2006502708A publication Critical patent/JP2006502708A/ja
Application granted granted Critical
Publication of JP4703186B2 publication Critical patent/JP4703186B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2004526684A 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法 Expired - Fee Related JP4703186B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200200187A SI21273A (sl) 2002-07-31 2002-07-31 Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
SIP-200200187 2002-07-31
PCT/EP2003/006134 WO2004015124A1 (en) 2002-07-31 2003-06-11 Process for the production of a heterologous protein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010254743A Division JP2011078421A (ja) 2002-07-31 2010-11-15 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Publications (2)

Publication Number Publication Date
JP2006502708A JP2006502708A (ja) 2006-01-26
JP4703186B2 true JP4703186B2 (ja) 2011-06-15

Family

ID=31713326

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004526684A Expired - Fee Related JP4703186B2 (ja) 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法
JP2010254743A Withdrawn JP2011078421A (ja) 2002-07-31 2010-11-15 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010254743A Withdrawn JP2011078421A (ja) 2002-07-31 2010-11-15 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Country Status (9)

Country Link
US (1) US20050283000A1 (https=)
EP (1) EP1527188B1 (https=)
JP (2) JP4703186B2 (https=)
AR (1) AR040719A1 (https=)
AT (1) ATE456665T1 (https=)
AU (1) AU2003250347A1 (https=)
DE (1) DE60331149D1 (https=)
SI (2) SI21273A (https=)
WO (1) WO2004015124A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21639A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtski pripravek, ki vsebuje nemicelarne sulfobetaine
EP1939212A1 (en) * 2006-12-20 2008-07-02 LEK Pharmaceuticals D.D. Organic compounds
WO2008096370A2 (en) * 2007-02-05 2008-08-14 Natco Pharma Limited An efficient and novel purification method of recombinant hg-csf
JPWO2008133141A1 (ja) * 2007-04-24 2010-07-22 東洋紡績株式会社 オスモチン組換えタンパク質およびその製造方法、並びにその利用
MX2010002448A (es) 2007-08-27 2010-10-04 Biogenerix Ag Formulacion liquida del g-csf conjugado.
US20090294362A1 (en) * 2008-05-30 2009-12-03 Persson Jonas Par Stationary phase for hydrophilic interaction chromatography
EP2542574B1 (en) * 2010-03-04 2017-08-09 Pfenex Inc. Method for producing soluble recombinant interferon protein without denaturing
AU2011235210B2 (en) 2010-04-01 2015-07-16 Pfenex Inc. Methods for G-CSF production in a Pseudomonas host cell
JP5836621B2 (ja) 2011-03-31 2015-12-24 株式会社マキタ 動力工具
HUP1200171A1 (hu) * 2012-03-19 2013-09-30 Richter Gedeon Nyrt Módszerek polipeptidek elõállítására
HUP1200172A2 (en) 2012-03-19 2013-10-28 Richter Gedeon Nyrt Methods for refolding g-csf from inclusion bodies
WO2014126871A1 (en) 2013-02-12 2014-08-21 Bristol-Myers Squibb Company Tangential flow filtration based protein refolding methods
US10065987B2 (en) 2013-02-12 2018-09-04 Bristol-Myers Squibb Company High pH protein refolding methods
RU2016117275A (ru) * 2013-11-01 2017-12-04 Сфериум Биомед С.Л. Тельца включения для трансдермальной доставки терапевтических и косметических средств
CN104152515B (zh) * 2014-08-14 2019-12-31 江苏奥赛康药业有限公司 一种制备重组人粒细胞集落刺激因子的培养基及发酵方法
JP2020080727A (ja) * 2018-11-26 2020-06-04 Ｓｐｉｂｅｒ株式会社 目的タンパク質の製造方法
KR20230044394A (ko) * 2020-06-09 2023-04-04 아이코사백스, 인크. 바이러스 유사 입자를 제조하는 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
IE912365A1 (en) * 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DE4037196A1 (de) * 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh Verfahren zur reaktivierung von denaturiertem protein
AU6028396A (en) * 1995-06-07 1996-12-30 Amgen, Inc. Ob protein compositions and method
US5912327A (en) * 1996-09-30 1999-06-15 Human Genome Sciences, Inc. Method of purifying chemokines from inclusion bodies
WO1998029542A1 (en) * 1996-12-27 1998-07-09 Japan Tobacco Inc. Floral organ-specific genes and promoter sequences thereof
US20020052026A1 (en) * 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6677139B1 (en) * 1999-12-23 2004-01-13 Genecor International, Inc. Methods for production of proteins in host cells
WO2003102013A2 (en) * 2001-02-23 2003-12-11 Gonzalez-Villasenor Lucia Iren Methods and compositions for production of recombinant peptides
SI21102A (sl) * 2001-12-19 2003-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika

Also Published As

Publication number Publication date
EP1527188B1 (en) 2010-01-27
SI1527188T1 (sl) 2010-05-31
WO2004015124A1 (en) 2004-02-19
EP1527188A1 (en) 2005-05-04
US20050283000A1 (en) 2005-12-22
JP2006502708A (ja) 2006-01-26
AR040719A1 (es) 2005-04-20
AU2003250347A1 (en) 2004-02-25
JP2011078421A (ja) 2011-04-21
DE60331149D1 (de) 2010-03-18
SI21273A (sl) 2004-02-29
ATE456665T1 (de) 2010-02-15

Similar Documents

Publication Publication Date Title
JP2011078421A (ja) 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法
JP2564506B2 (ja) 異種タンパク質の製造方法
WO2008096370A2 (en) An efficient and novel purification method of recombinant hg-csf
US6773899B2 (en) Phage-dependent superproduction of biologically active protein and peptides
AU2001284914A1 (en) Phage-dependent Superproduction of Biologically Active Protein and Peptides
Restrepo-Pineda et al. The pre-induction temperature affects recombinant HuGM-CSF aggregation in thermoinducible Escherichia coli
CN118373918A (zh) 一种日本鳗鲡gdf-9重组蛋白及其表达方法与应用
CN1230542C (zh) 通过自我蛋白水解生产蛋白质
JP2015514398A (ja) ポリペチドの生産方法
JP5830032B2 (ja) インターフェロンアルファ５を生産する方法
Dehaghani et al. An efficient purification method for high recovery of recombinant human granulocyte colony stimulating factor from recombinant E. coli
HU210428B (en) Method for extraction of human interleukin-4 from bacteria
Rao et al. A purification method for improving the process yield and quality of recombinant human granulocyte colony‐stimulating factor expressed in Escherichia coli and its characterization
CN1088107C (zh) 人粒细胞巨噬细胞集落刺激因子制备方法及其表达载体和工程菌
JP2844484B2 (ja) 組換え蛋白質の生産方法
JP2005503784A (ja) 発酵培地及び方法
CN117737163A (zh) 一种提高重组人源化胶原蛋白生产水平的发酵工艺
RU2242516C1 (ru) Способ получения рекомбинантного человеческого интерферона альфа-2b, рекомбинантная плазмида и штамм продуцент для его осуществления
WO2008074724A1 (en) Organic compounds
ES2281822T3 (es) Vectores de expresion, celulas huesped transformadas y procedimiento de fermentacion para la produccion de polipeptidos recombinantes.
RU2319502C1 (ru) РАСТВОР ДЛЯ ИНЪЕКЦИЙ, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pSX50, КОДИРУЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА, ШТАММ Escherichia coli SX50 - ПРОМЫШЛЕННЫЙ ШТАММ-ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА И СПОСОБ ПРОМЫШЛЕННОГО ПОЛУЧЕНИЯ ИНТЕРФЕРОНА АЛЬФА-2b
US9982012B2 (en) Refolding of granulocyte colony stimulating factor
EP2912173B1 (en) Process for preparation and purification of recombinant human oncostatin m protein
EA013263B1 (ru) Способ получения интерферона-бета
KR100235461B1 (ko) 재조합 미생물의 발효시 생산되는 생리 활성 단백질의 산화, 환원 조절 방법

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060605

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090330

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090706

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100713

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101115

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110118

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110215

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110308

R150 Certificate of patent or registration of utility model

Ref document number: 4703186

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees